Management options for refractory bleeding include balloon tamponade or Danis Ella stent (bridging therapies), interventional radiology-guided TIPS (IR-TIPS)/balloon-occluded retrograde transvenous obliteration and surgery.
Essential considerations involve terlipressin/octreotide, ceftriaxone, metoclopramide (erythromycin), maintaining mean arterial pressure at ~65 mmHg, securing the airway for HE or continuous bleeding, monitoring ECG and electrolytes, conducting a CT scan for anatomy, hepatocellular carcinoma (HCC) and portal vein thrombosis; involving insulin resistance and maintaining hemoglobin at 7-8 g/dL.
No FFPS is recommended, and TEG-based correction may offer better outcomes. Risk factors for re-bleeding include MELD >17, HVPG >20 and PPG >21.
Post-endoscopic variceal ligation (EVL) monitoring is crucial.
The use of self-expanding metal stents (SEMS) is preferred if available and affordable, with salvage TIPS considered superior to surgery for cirrhosis.
Conversely, surgery is favored over TIPS for extrahepatic portal vein obstruction
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article